Advertisement

---

KEMPHARM, INC.

KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

[2013-06-11] -


KemPharm's KP201 Featured at the International Conference on Opioids

[2013-06-04] - Poster Presentation to Highlight KP201's Unique Abuse-Deterrent Properties and Its Potential to Prevent or Reduce Opioid-Induced Constipation


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers